+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lipid Microbubble Ultrasound Contrast Agent Market by Application (Cardiovascular Imaging, Oncology, Radiology), End User (Ambulatory Surgical Centers, Clinics, Diagnostic Imaging Centers), Product Type, Distribution Channel - Global Forecast 2025-2030- Product Image
Lipid Microbubble Ultrasound Contrast Agent Market by Application (Cardiovascular Imaging, Oncology, Radiology), End User (Ambulatory Surgical Centers, Clinics, Diagnostic Imaging Centers), Product Type, Distribution Channel - Global Forecast 2025-2030- Product Image
New

Lipid Microbubble Ultrasound Contrast Agent Market by Application (Cardiovascular Imaging, Oncology, Radiology), End User (Ambulatory Surgical Centers, Clinics, Diagnostic Imaging Centers), Product Type, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6152052
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Unveiling the Transformative Technologies and Clinical Advancements Shaping the Lipid Microbubble Ultrasound Contrast Agent Industry Evolution

The field of lipid microbubble ultrasound contrast agents is advancing at an unprecedented pace, driven by continuous innovation in molecular engineering and imaging modalities. Over the past decade, researchers have refined microbubble formulations to improve acoustic stability and targeted delivery, enhancing both the safety profile and diagnostic accuracy of ultrasound procedures. As these agents transition from preclinical validation to broader clinical adoption, they are redefining established protocols across cardiovascular, oncological, and radiological applications.

Innovative collaborations among academic institutions, clinical research centers, and industry players have fostered the development of next-generation lipid shells and gas cores designed to optimize contrast enhancement. These collaborative efforts have not only expanded the potential diagnostic utility of microbubbles but also spurred regulatory agencies to update guidelines that accommodate evolving safety and efficacy data. As a result, ultrasound imaging is emerging as a versatile, cost-effective alternative to traditional modalities, positioning lipid microbubble contrast agents as pivotal tools in the non-invasive visualization of tissue perfusion and molecular markers.

Key Forces Catalyzing Paradigm Shifts in the Lipid Microbubble Ultrasound Contrast Agent Landscape and Their Strategic Implications

The landscape of ultrasound contrast agents has undergone transformative shifts, shaped by breakthroughs in targeted delivery and emerging clinical demands. Innovations in ligand conjugation have facilitated the creation of microbubbles capable of homing in on specific biomarkers, enabling the real-time visualization of molecular processes without invasive procedures. This shift toward precision imaging reflects a broader trend in personalized medicine, where diagnostic tools are tailored to individual patient profiles and disease phenotypes.

Meanwhile, the integration of artificial intelligence and advanced signal processing algorithms has revolutionized image interpretation, allowing clinicians to extract quantitative perfusion metrics with greater consistency. These technological enhancements are complemented by streamlined manufacturing processes that leverage microfluidic platforms, ensuring high batch-to-batch uniformity and scalable production. Collectively, these forces have redefined stakeholder expectations, demanding contrast agents that not only offer superior imaging performance but also align with evolving safety standards and cost-efficiency requirements.

Assessing the Reverberating Effects of Newly Imposed United States Tariffs on Lipid Microbubble Ultrasound Contrast Agent Supply Chains and Market Strategies

The introduction of new tariffs by the United States has reverberated throughout global supply chains for lipid microbubble ultrasound contrast agents, prompting manufacturers to reevaluate sourcing strategies. With increased duties impacting critical components such as phospholipid precursors and specialty gases, companies have responded by diversifying their procurement networks and exploring localized production capabilities. These adjustments aim to mitigate price volatility and safeguard continuity of supply in the face of trade policy uncertainties.

In parallel, tariff-induced cost pressures have accelerated the pursuit of alternative raw materials and green synthesis pathways, as organizations seek to reduce dependency on heavily taxed imports. Research teams are investigating bio-based lipid sources and gas-compression techniques that require fewer specialized reagents. As a result, the industry is witnessing a reframing of manufacturing priorities, emphasizing supply chain resilience, regulatory compliance, and sustainable innovation to navigate the evolving trade environment.

Deep Diving into Segmentation Insights to Reveal Hidden Opportunity Pathways across Applications End Users Product Types and Distribution Channels

Understanding the nuanced needs of clinicians and patients requires a deep dive into segment-driven insights, which reveal the differentiated demand patterns across clinical use cases and distribution pathways. In cardiovascular imaging, echocardiography applications remain central to early detection and management of heart disease, while peripheral vascular imaging relies on microbubble-enhanced scans to visualize blood flow anomalies. Oncology leverages targeted microbubbles for tumor angiogenesis assessment in breast, liver, and prostate contexts, enabling clinicians to refine treatment plans based on vascular characteristics. Radiology has embraced hepatic, pancreatic, and renal imaging enhancements that provide higher resolution perfusion maps, supporting early-stage disease monitoring.

End users ranging from ambulatory surgical centers to large hospital networks demonstrate distinct preferences for contrast agent formats and delivery frameworks. Diagnostic imaging centers prioritize ease of handling and shelf life stability, whereas clinics value cost efficiency and rapid turnaround times. Product developers also differentiate between non targeted agents for broad diagnostic use and targeted formulations in clinical and preclinical development stages, each backed by growth factor, integrin, antibody, or peptide targeting strategies. Distribution models vary across direct sales and indirect channels, with online platforms and distributor partnerships balancing reach with localized support and compliance requirements.

Evaluating Regional Dynamics to Uncover Growth Prospects and Adoption Patterns in the Americas Europe Middle East Africa and Asia Pacific Markets

Regional dynamics play a crucial role in shaping the adoption and innovation trajectories of lipid microbubble ultrasound contrast agents. In the Americas, regulatory bodies have established clear approval pathways and reimbursement frameworks that encourage market entry and the uptake of cutting-edge formulations. Research collaborations between North American universities and industry consortia continue to yield advanced microbubble chemistries, fostering a competitive yet collaborative ecosystem.

Across Europe, the Middle East, and Africa, diverse healthcare infrastructures create pockets of early adoption alongside regions where cost constraints limit widespread utilization. Regulatory harmonization efforts within the European Union have streamlined product registration processes, while emerging markets in the Middle East and Africa benefit from capacity-building initiatives led by global health organizations. Asia-Pacific exhibits a high degree of heterogeneity, with established markets in Japan and Australia driving innovation and rapidly growing economies such as India and China expanding their diagnostic imaging capabilities.

These regional differences underscore the importance of tailored market entry and commercialization strategies that align with local regulatory landscapes, reimbursement policies, and clinician training programs. By acknowledging the unique dynamics across each geographic corridor, industry stakeholders can optimize resource allocation and accelerate contrast agent diffusion.

Profiling Leading Innovators and Strategic Collaborators Driving the Evolution of Lipid Microbubble Ultrasound Contrast Agents

A cohort of leading companies is spearheading advancements in lipid microbubble ultrasound contrast agents by focusing on platform scalability, novel targeting mechanisms, and strategic partnerships. Emerging innovators specialize in microfluidic manufacturing technologies that deliver high uniformity and throughput, providing a foundation for rapid clinical translation. Simultaneously, established pharmaceutical and medical imaging firms are channeling investments into R&D collaborations aimed at developing next-generation contrast agents with dual diagnostic and therapeutic functionalities.

Partnerships between academic spin-offs and contract manufacturing organizations have streamlined the progression from proof-of-concept to commercial readiness. These collaborations leverage complementary expertise, combining molecular biology platforms with precision engineering capabilities to refine shell composition and gas encapsulation. Furthermore, alliances with imaging equipment providers have enabled co-development initiatives that optimize ultrasound hardware settings for enhanced microbubble visualization, securing a cohesive value proposition for end users.

Actionable Strategic Priorities for Industry Leaders to Accelerate Adoption and Achieve Competitive Differentiation in Contrast Agent Solutions

Industry leaders should prioritize the development of modular manufacturing systems that accommodate both targeted and non targeted formulations, ensuring rapid scalability while maintaining stringent quality standards. Investing in cross-functional teams that integrate regulatory affairs, clinical development, and supply chain management will facilitate seamless navigation of evolving trade policies and approval requirements. Additionally, establishing strategic alliances with academic research centers can accelerate access to novel ligands and microbubble shell technologies, creating differentiated value propositions.

Leaders must also embrace data-driven commercialization models by integrating real-world evidence collection into early-phase clinical studies. This approach will enable rapid refinement of contrast agent performance metrics and support favorable coverage decisions from payers. Finally, expanding digital engagement channels-such as immersive training modules and remote technical support-will strengthen customer relationships and drive sustained adoption of advanced ultrasound imaging solutions.

Robust Research Methodology Framework Highlighting Data Collection Analytical Techniques and Validation Processes Underpinning Industry Insights

This research leverages a mixed-methods approach, combining primary interviews with key opinion leaders, including radiologists, cardiologists, and regulatory experts, alongside secondary data analysis from peer-reviewed journals, patent filings, and conference proceedings. Quantitative insights were validated through structured industry surveys, while qualitative findings were cross-referenced against clinical trial registries and safety databases to ensure robustness.

Advanced analytical techniques, such as thematic coding and scenario planning, were applied to identify emerging technological trends and potential regulatory shifts. Supply chain resilience was assessed through risk-mapping exercises and logistic modeling, while segmentation insights were derived from cluster analysis of end user preferences and application-specific usage patterns. This rigorous methodology ensures a comprehensive understanding of market dynamics and equips stakeholders with credible, actionable intelligence.

Synthesizing Core Findings to Illuminate Key Takeaways Guiding Future Directions in Lipid Microbubble Ultrasound Contrast Agent Development

The analysis underscores the critical role of targeted microbubble formulations in advancing personalized diagnostic imaging, particularly in oncology and cardiovascular applications. Supply chain adaptability has emerged as a decisive factor in sustaining production continuity amid shifting trade policies. Regional regulatory harmonization and reimbursement frameworks are key determinants of market penetration rates across diverse geographies.

Segmentation-driven strategies reveal that aligning product portfolios with specific clinical workflows and distribution preferences will enhance market receptivity. Strategic collaborations between innovators, contract manufacturers, and imaging equipment providers promise to accelerate time-to-market for next-generation contrast agents. By integrating real-world evidence and digital support channels, stakeholders can foster clinician trust and drive adoption. These insights collectively illuminate a path forward for industry participants aiming to capitalize on the expanding utility of lipid microbubble ultrasound contrast agents.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Cardiovascular Imaging
      • Echocardiography
      • Peripheral Vascular Imaging
    • Oncology
      • Breast Tumor Detection
      • Liver Tumor Detection
      • Prostate Tumor Detection
    • Radiology
      • Hepatic Imaging
      • Pancreatic Imaging
      • Renal Imaging
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Diagnostic Imaging Centers
    • Hospitals
  • Product Type
    • Non Targeted
    • Targeted
      • Clinical Development Stage
        • Growth Factor Targeted
        • Integrin Targeted
      • Preclinical Development Stage
        • Antibody Targeted
        • Peptide Targeted
  • Distribution Channel
    • Direct Sales
    • Indirect Sales
      • Distributors
      • Online Sales
        • Company Websites
        • Ecommerce Platforms
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Lantheus Holdings, Inc.
  • Bracco Imaging S.p.A.
  • General Electric Company
  • Fujifilm Toyama Chemical Co., Ltd.
  • Daiichi Sankyo Company, Limited

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of AI powered imaging systems to enhance lipid microbubble contrast resolution
5.2. Development of targeted therapeutic microbubbles for site specific drug delivery in oncology patients
5.3. Regulatory approvals driving commercialization of next generation lipid microbubble formulations with extended shelf life
5.4. Increasing research collaborations between imaging device manufacturers and pharmaceutical companies for multifunctional microbubbles
5.5. Innovations in dual modality ultrasound and photoacoustic imaging using lipid based microbubble contrast agents
5.6. Rising demand for point of care ultrasound diagnostics integrating lipid microbubble contrast for vascular assessments
5.7. Expansion of personalized medicine approaches leveraging ligand targeted microbubbles for molecular imaging
5.8. Advances in real time monitoring of microbubble cavitation effects to optimize ultrasound guided therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Lipid Microbubble Ultrasound Contrast Agent Market, by Application
8.1. Introduction
8.2. Cardiovascular Imaging
8.2.1. Echocardiography
8.2.2. Peripheral Vascular Imaging
8.3. Oncology
8.3.1. Breast Tumor Detection
8.3.2. Liver Tumor Detection
8.3.3. Prostate Tumor Detection
8.4. Radiology
8.4.1. Hepatic Imaging
8.4.2. Pancreatic Imaging
8.4.3. Renal Imaging
9. Lipid Microbubble Ultrasound Contrast Agent Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Clinics
9.4. Diagnostic Imaging Centers
9.5. Hospitals
10. Lipid Microbubble Ultrasound Contrast Agent Market, by Product Type
10.1. Introduction
10.2. Non Targeted
10.3. Targeted
10.3.1. Clinical Development Stage
10.3.1.1. Growth Factor Targeted
10.3.1.2. Integrin Targeted
10.3.2. Preclinical Development Stage
10.3.2.1. Antibody Targeted
10.3.2.2. Peptide Targeted
11. Lipid Microbubble Ultrasound Contrast Agent Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Indirect Sales
11.3.1. Distributors
11.3.2. Online Sales
11.3.2.1. Company Websites
11.3.2.2. Ecommerce Platforms
12. Americas Lipid Microbubble Ultrasound Contrast Agent Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Lipid Microbubble Ultrasound Contrast Agent Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Lipid Microbubble Ultrasound Contrast Agent Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Lantheus Holdings, Inc.
15.3.2. Bracco Imaging S.p.A.
15.3.3. General Electric Company
15.3.4. Fujifilm Toyama Chemical Co., Ltd.
15.3.5. Daiichi Sankyo Company, Limited
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET: RESEARCHAI
FIGURE 24. LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET: RESEARCHSTATISTICS
FIGURE 25. LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET: RESEARCHCONTACTS
FIGURE 26. LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ECHOCARDIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ECHOCARDIOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PERIPHERAL VASCULAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PERIPHERAL VASCULAR IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY BREAST TUMOR DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY BREAST TUMOR DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY LIVER TUMOR DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY LIVER TUMOR DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PROSTATE TUMOR DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PROSTATE TUMOR DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY HEPATIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY HEPATIC IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PANCREATIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PANCREATIC IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RENAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RENAL IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY NON TARGETED, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY NON TARGETED, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY GROWTH FACTOR TARGETED, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY GROWTH FACTOR TARGETED, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INTEGRIN TARGETED, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INTEGRIN TARGETED, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ANTIBODY TARGETED, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ANTIBODY TARGETED, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PEPTIDE TARGETED, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PEPTIDE TARGETED, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 143. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 146. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 147. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 148. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 149. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2018-2024 (USD MILLION)
TABLE 150. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2025-2030 (USD MILLION)
TABLE 151. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2018-2024 (USD MILLION)
TABLE 156. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2025-2030 (USD MILLION)
TABLE 157. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 158. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 159. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 160. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 161. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 164. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 165. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 166. CANADA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 167. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 170. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 171. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 172. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 173. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2018-2024 (USD MILLION)
TABLE 174. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2025-2030 (USD MILLION)
TABLE 175. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2018-2024 (USD MILLION)
TABLE 180. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2025-2030 (USD MILLION)
TABLE 181. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 182. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 183. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 184. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 185. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 188. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 189. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 190. MEXICO LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY RADIOLOGY, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY TARGETED, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY CLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY PRECLINICAL DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA LIPID MICROBUBBLE ULTRASOUND CONTRAST AGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM LIPID MICROBUBBLE ULTRASOUND C

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Lipid Microbubble Ultrasound Contrast Agent Market report include:
  • Lantheus Holdings, Inc.
  • Bracco Imaging S.p.A.
  • General Electric Company
  • Fujifilm Toyama Chemical Co., Ltd.
  • Daiichi Sankyo Company, Limited

Related Topics

Related Reports

Perfluorocarbon-based Ultrasound Contrast Agents Market by Application (Cardiology, Oncology, Radiology), Technology Type (Liquids, Microbubbles, Nanobubbles), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Perfluorocarbon-based Ultrasound Contrast Agents Market by Application (Cardiology, Oncology, Radiology), Technology Type (Liquids, Microbubbles, Nanobubbles), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Contrast Media API Market by Product Type (Barium-Based, Gadolinium-Based, Iodine-Based), Application (Computed Tomography, Magnetic Resonance Imaging, Ultrasound Imaging), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Contrast Media API Market by Product Type (Barium-Based, Gadolinium-Based, Iodine-Based), Application (Computed Tomography, Magnetic Resonance Imaging, Ultrasound Imaging), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Ultrasonic Microbubble Contrast Agents Market by Application (Cardiovascular, Gastroenterology, Oncology), Product Type (Multi Bubble, Single Bubble, Targeted Agent), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Ultrasonic Microbubble Contrast Agents Market by Application (Cardiovascular, Gastroenterology, Oncology), Product Type (Multi Bubble, Single Bubble, Targeted Agent), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Microbubbles/Ultrasound Contrast Agent Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Microbubbles/Ultrasound Contrast Agent Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 85 Pages
  • Global
From
Sulfur Hexafluoride Microbubbles for Injection Market by Application (Cardiovascular, Neurological, Oncological), End User (Ambulatory Surgery Centers, Diagnostic Centers, Hospitals), Product Type, Administration Route - Global Forecast 2025-2030 - Product Image

Sulfur Hexafluoride Microbubbles for Injection Market by Application (Cardiovascular, Neurological, Oncological), End User (Ambulatory Surgery Centers, Diagnostic Centers, Hospitals), Product Type, Administration Route - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.